Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1797]
News [2683]
Articles [195]
Editorials [1]
Conferences [135]
elearning [13]
New global research aims to improve survival rates for pancreatic cancer patients
New global research aims to improve survival rates for pancreatic cancer patients
Research findings may lead to improved treatments for chemotherapy-resistant ovarian cancer
Research findings may lead to improved treatments for chemotherapy-resistant ovarian cancer
New glioblastoma treatment reaches human brain tumour and helps immune cells recognise cancer cells
New glioblastoma treatment reaches human brain tumour and helps immune cells recognise cancer cells
Molecular pathway that impacts pancreatic cancer progression and response to treatment detailed
Molecular pathway that impacts pancreatic cancer progression and response to treatment detailed
ASCO 2024: Sarcoma clinical trial reduces risk of relapse by 43%
ASCO 2024: Sarcoma clinical trial reduces risk of relapse by 43%
ASCO 2024: Immunotherapy significantly increases the number of patients free from bowel cancer
ASCO 2024: Immunotherapy significantly increases the number of patients free from bowel cancer
ASCO 2024: Research group completes first trial of Black patients with early-stage breast cancer
ASCO 2024: Research group completes first trial of Black patients with early-stage breast cancer
ASCO 2024: Chemotherapy before and after surgery may be new standard treatment for some patients with oesophageal cancer
ASCO 2024: Chemotherapy before and after surgery may be new standard treatment for some patients with oesophageal...
ASCO 2024: Durvalumab following chemoradiotherapy improved survival in patients with limited-stage small-cell lung cancer
ASCO 2024: Durvalumab following chemoradiotherapy improved survival in patients with limited-stage small-cell lung...
ASCO 2024: Novel therapy combination more effective at treating Hodgkin lymphoma than established treatment
ASCO 2024: Novel therapy combination more effective at treating Hodgkin lymphoma than established treatment

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation